Tumour eradication by antiangiogenic therapy: Analysis and extensions of the model by Hahnfeldt et al. (1999)

Mathematical Biosciences

Volumn 191, Issue 2, 2004, Pages 159-184

  D'Onofrio, Alberto ^a   Gandolfi, Alberto ^b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b Italy   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DRUG DOSAGE; GENES; OXYGEN; TUMORS;

ANTIANGIOGENIC THERAPY; NUTRIENTS; TUMOR GROWTH; VASCULAR NETWORK;

BIOMECHANICS;

ANGIOGENESIS INHIBITOR;

TUMOR;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; DRUG EFFECT; ENDOTHELIUM CELL; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 4444221249     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mbs.2004.06.003     Document Type: Article

References (39)

1. J. Folkman Tumor angiogenesis Adv. Cancer Res. 43 1985 175
2. W. Mueller-Klieser Multicellular spheroids. A review on cellular aggregates in cancer research J. Cancer Res. Clin. Oncol. 113 1987 101
3. J.A. Adam General aspects of modeling tumor growth and immune response J.A. Adam N. Bellomo A Survey of Models for Tumor-Immune System Dynamics 1997 Birkhäuser Boston 187
4. H.M. Byrne A weakly nonlinear analysis of a model of avascular solid tumour growth J. Math. Biol. 39 1999 59
5. J.P. Ward J.R. King Mathematical modelling of avascular-tumour growth II: Modelling growth saturation IMA J. Math. Appl. Med. Biol. 16 1999 171
6. J.P. Ward J.R. King Mathematical modelling of drug transport in tumour multicell spheroids and monolayer cultures Math. Biosci. 181 2003 177
7. P. Carmeliet R.K. Jain Angiogenesis in cancer and other diseases Nature 249 2000 249
8. G.D. Yancopoulos S. Davis N.W. Gale J.S. Rudge S.J. Wiegand J. Holash Vascular-specific growth factors and blood vessel formation Nature 407 2000 242
9. M.A.J. Chaplain From mutation to metastasis: the mathematical modelling of the stages of tumour development J.A. Adam N. Bellomo A Survey of Models for Tumor-Immune System Dynamics 1997 Birkhäuser Boston 187
10. A.R.A. Anderson M.A.J. Chaplain Continuous and discrete mathematical models of tumor-induced angiogenesis Bull. Math. Biol. 60 1998 857
11. P. Hahnfeldt D. Panigrahy J. Folkman L. Hlatky Tumor development under angiogenic signalling: A dynamic theory of tumor growth, treatment response, and postvascular dormancy Cancer Res. 59 1999 4770
12. M.S. O’Reilly L. Holmgren Y. Shing C. Chen R.A. Rosenthal M. Moses W.S. Lane Y. Cao E.H. Sage J. Folkman Angiostatin. A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 79 1994 315
13. M.S. O’Reilly T. Boehm Y. Shing N. Fukai G. Vasios W.S. Lane E. Flynn J.R. Birkhead B.R. Olsen J. Folkman Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 1977 277
14. S. Ramanujan G.C. Koenig T.P. Padera B.R. Stoll R.K. Jain Local imbalance of proangiogenic and antiangiogenic factors: A potential mechanism of focal necrosis and dormancy in tumors Cancer Res. 60 2000 1442
15. E. De Angelis L. Preziosi Advection–diffusion models for solid tumour evolution in vivo and related free boundary problems Math. Models Methods Appl. Sci. 10 2000 379
16. J.L. Jackson Vascular tumor growth and treatment: Consequences of polyclonality, competition and dynamic vascular support J. Math. Biol. 44 2002 201
17. C.J.W. Breward H.M. Byrne C.E. Lewis A multiphase model describing vascular tumour growth Bull. Math. Biol. 65 2003 609 640
18. L. Arakelyan V. Vainstein Z. Agur A computer algorithm describing the process of vessel formation and maturation, and its use for predicting the effects of anti-angiogenic and anti-maturation therapy on vascular tumour growth Angiogenesis 5 2003 203
19. Z. Agur L. Arakelyan P. Daugulis Y. Ginosar Hopf point analysis for angiogenic models Discr. Cont. Dyn. Sys.-B 4 2004 29
20. A. Ergun K. Camphausen L.M. Wein Optimal scheduling of radiotherapy and angiogenic inhibitors Bull. Math. Biol. 65 2003 407
21. T. Boehm J. Folkman T. Browder M.S. O’Reilly Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance Nature 390 1997 404
22. R.S. Kerbel A cancer therapy resistant to resistance Nature 390 1997 335
23. T. Browder C.E. Butterfield B.M. Kräling B. Shi B. Marshall M.S. O’Reilly J. Folkman Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer Cancer Res. 60 2000 1878
24. R.S. Kerbel G. Klement K.I. Pritchard B. Kamen Continuous low-dose anti-angiogenic/metronomic chemotherapy: from the research laboratory into the oncology clinic Ann. Oncol. 13 2002 12
25. R.K. Sachs L.R. Hlatky P. Hahnfeldt Simple ODE models of tumor growth and anti-angiogenic or radiation treatment Math. Comput. Mod. 33 2001 1297
26. S. Ahmad A nonstandard resonance problem for ordinary differential equations Trans. Am. Math. Soc. 323 1991 857
27. J.C. Panetta A mathematical model of periodically pulsed chemotherapy: Tumor recurrence and metastasis in a competitive environment Bull. Math. Biol. 88 1996 425
28. A. Lakmeche O. Arino Nonlinear mathematical model of pulsed-therapy of heterogeneous tumors Nonlinear Anal.: Real World Appl. 2 2001 455
29. I.F. Tannock Population kinetics of carcinoma cells, capillary endothelial cells, and fibroblasts in a transplanted mouse mammary tumor Cancer Res. 30 1970 2470
30. J. Denekamp B. Hobson Endothelial-cell proliferation in experimental tumours Br. J. Cancer 46 1982 711
31. D.G. Hirst J. Denekamp B. Hobson Proliferation kinetics of endothelial and tumour cells in three mouse mammary carcinomas Cell Tissue Kinet. 15 1982 251
32. H.R. Thieme Convergence results and a Poincare’-Bendixson thricothomy for asymptotically autonomous differential equations J. Math. Biol. 30 1992 755
33. W.A. Coppel Stability and Asymptotic Behavior of Differential Equations 1965 D.C. Heath and Company Boston
34. P. Hahnfeldt J. Folkman L. Hlatky Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis J. Theor. Biol. 220 2003 545
35. B.F. Dibrov A.M. Zhabotinsky M.P. Neyfakh M.P. Orlova L.I. Churykova Mathematical model of cancer chemotherapy, Periodic schedules of phase-specific cytotoxic-agents administration increasing the selectivity of therapy Math. Biosci. 73 1985 1
36. Z. Agur R. Arnon B. Schachter Reduction of cytotoxicity to normal tissue by new regimens of phase-specific drugs Math. Biosci. 92 1988 1
37. A. Swierniak A. Polanski M. Kimmel Optimal control problems arising in cell-cycle-specific cancer chemotherapy Cell Prolif. 29 1996 117
38. J. Holash P.C. Maisonpierre D. Compton P. Boland C.R. Alexander D. Zagzag G.D. Yancopoulos S.J. Wiegand Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF Science 284 1999 1994
39. A. Bertuzzi A. d’Onofrio A. Fasano A. Gandolfi Regression and regrowth of tumour cords following single-dose anticancer treatment Bull. Math. Biol. 65 2003 903